Dietary considerations in migraine management: Does a consistent diet improve migraine? Topical collection on migraine

Current Pain and Headache Reports

Volumn 17, Issue 11, 2013, Pages

  Finkel, Alan G ^a   Yerry, Juanita A ^a   Mann, J Douglas ^b  

^a Carolina Headache Institute   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Diet; Inflammation; Inflammatory Bowel Disease; Lifestyle; Migraine; Obesity; Orexin; Triggers; Umami

Indexed keywords

GLUTAMATE SODIUM; GLUTEN;

ARTICLE; COMORBIDITY; CROHN DISEASE; DAIRY PRODUCT; DIET THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FOOD ALLERGY; FOOD COMPOSITION; FOOD INTAKE; HUMAN; INFLAMMATORY DISEASE; IRRITABLE COLON; LIFESTYLE; MIGRAINE; NONHUMAN; OBESITY; ATTITUDE TO HEALTH; COMPLICATION; DIET; DRINKING BEHAVIOR; EPIDEMIOLOGY; FEMALE; GASTROINTESTINAL DISEASES; IMMUNOLOGY; INFLAMMATION; MALE; MIGRAINE DISORDERS; RISK REDUCTION;

ALCOHOL DRINKING; DAIRY PRODUCTS; DIET; FEMALE; FOOD HYPERSENSITIVITY; GASTROINTESTINAL DISEASES; GLUTENS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLAMMATION; MALE; MIGRAINE DISORDERS; OBESITY; PRECIPITATING FACTORS; RISK REDUCTION BEHAVIOR; SODIUM GLUTAMATE;

MLCS; MLOWN;

EID: 84887031181     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-013-0373-4     Document Type: Article

References (83)

1. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38(7):497-506. (Pubitemid 28429337)
2. Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, et al. 3 Depression and risk of transformation of episodic to chronic migraine. J Headache Pain. 2012;13(8):615-24.
3. Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, et al. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache. 2012;52(1):3-17.
4. Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol. 2009;22(3):269-76.
5. Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB. Body mass index and episodic headaches: a population-based study. Arch Intern Med. 2007;167(18):1964-70. (Pubitemid 47606636)
6. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression (or for chronic daily headaches)-clinical lessons. Headache. 2006;46 Suppl 3:S144-6. (Pubitemid 44521786)
7. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67(2):252-7. (Pubitemid 44305408)
8. Bigal ME, Gironda M, Tepper SJ, Feleppa M, Rapoport AM, Sheftell FD, et al. Headache prevention outcome and body mass index. Cephalalgia. 2006;26(4):445-50.
9. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66(4):545-50. (Pubitemid 43739885)
10. Dimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache. 2013;53(2):344-55.
11. Rai MF, Sandell LJ. Inflammatory mediators: tracing links between obesity and osteoarthritis. Crit Rev Eukaryot Gene Expr. 2011;21(2):131-42.
12. • Bond DS, O'Leary KC, Thomas JG, Lipton RB, Papandonatos GD, Roth J, et al. Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial. Contemp Clin Trials. 2013;35(1):133-44. In a well written paper explaining the rationale and methodology for studying the link between obesisty and migraine and chronic migraine, the authors provide details including statistical approaches. By describing the process of study, additional investigators may bypass pitfalls in studying these two concurrent disorders.
13. Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30(9):1065-72.
14. Diamond M. The impact of migraine on the health and well-being of women. J Womens Health (Larchmt). 2007;16(9):1269-80. (Pubitemid 350125866)
15. Judit A, Sándor PS, Schoenen J. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia. 2000;20(8):714-9. (Pubitemid 32127839)
16. Sener HO, Haktanir I, Demirci S. Pattern-reversal visual evoked potentials in migraineurs with or without visual aura. Headache. 1997;37(7):449-51. (Pubitemid 27360697)
17. Woestenburg JC, Kramer CJ, Orlebeke JF, Passchier J. Brain potential differences related to spatial attention in migraineurs with and without aura symptoms support supposed differences in activation. Headache. 1993;33(8):413-6. (Pubitemid 23296976)
18. Calhoun A, Ford S. Elimination of menstrual-related migraine beneficially impacts chronicifcation and medication overuse. Headache. 2008;48(8):1186-93.
19. Johnson KG, Ziemba AM, Garb JL. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea: a retrospective analysis. Headache. 2013;53(2):333-43.
20. Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback. 2002;27(2):163-81. (Pubitemid 34848001)
21. Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178-83. (Pubitemid 47457761)
22. Nappi G, Jensen R, Nappi RE, Sances G, Torelli P, Olesen J. Diaries and calendars for migraine. A review. Cephalalgia. 2006;26(8):905-16. (Pubitemid 44079713)
23. Winner P. Migraine-related symptoms in childhood. Curr Pain Headache Rep. 2013;17(9):339.
24. Guidetti V, Galli F, Cerutti R, Fortugno S. "From 0 to 18": what happens tithe child and his headache? Funct Neurol. 2000;15 Suppl 3:122-9. (Pubitemid 32051384)
25. Chai NC, Shapiro RE, Rapoport AM. Why does vomiting stop a migraine attack? Curr Pain Headache Rep. 2013;17(9):362.
26. Becker WL. Migraine-associated symptoms: clinical significance and management. Can J Clin Pharmacol. 1999;6(Suppl A):15A-9A.
27. Aurora SK, Papapetropoulos S, Kori SH, Kedar A, Abell TL. Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications. Cephalalgia. 2013;33(6):408-15.
28. Charles A. The evolution of a migraine attack - a review of recent evidence. Headache. 2013;53(2):413-9.
29. • Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain. 2013. doi: 10.1016/j.pain.2013.07. 021. A review of contemporary ideas in translating the biology and anatomy of the nervous system into and understanding of migraine, this paper offers the reader a one-stop description. The relevance to the understanding of all of headache medicine is worth the read.
30. Yaman M, Ucok K, Demirbas H, Genc A, Oruc S, Karabacak H, et al. Effects of topiramate use on body composition and resting metabolic rate in migraine patients. Neurol Sci. 2013;34(2):225-9.
31. Lakhanpal D, Kataria H, Kaur G. Neuroendocrine plasticity in GnRH release is disrupted by valproic acid treatment of cycling rats. Acta Neurol Belg. 2011;111(2):121-9.
32. Ray ST, Kumar R. Migraine and obesity: cause or effect? Headache. 2010;50(2):326-8.
33. • Finocchi C, Sivori G. Food as trigger and aggravating factor of migraine. Neurol Sci. 2012;33 Suppl 1:S77-80. Reviewing the knowledge to date, this paper details the knowns and unknowns of food triggers. It helps the reader understand the ephemeral nature of this target for treatment.
34. Sensenig J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev. 2001;6(5):488-94. (Pubitemid 33041796)
35. Monro J, Carini C, Brostoff J. Migraine is a food-allergic disease. Lancet. 1984;2(8405):719-21. (Pubitemid 14037036)
36. Monro J, Brostoff J, Carini C, Zilkha K. Food allergy in migraine. Study of dietary exclusion and RAST. Lancet. 1980;2(8184):1-4. (Pubitemid 10123284)
37. Giacovazzo M, Martelletti P. Migraine: a food-related immune reaction? Ann Allergy. 1989;63(3):255.
38. Bruno PP, Carpino F, Carpino G, Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci. 2007;11(4):245-8. (Pubitemid 47468056)
39. Marcus DA, Scharff L, Turk D, Gourley LM. A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia. 1997;17(8):855-62. (Pubitemid 28034350)
40. Panconesi A. Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain. 2008;9(1):19-27.
41. Hauge AW, Kirchmann M, Olesen J. Characterization of consistent triggers of migraine with aura. Cephalalgia. 2011;31(4):416-38.
42. Abu-Salameh I, Plakht Y, Ifergane G. Migraine exacerbation during Ramadan fasting. J Headache Pain. 2010;11(6):513-7.
43. Drescher MJ, Elstein Y. Prophylactic COX 2 inhibitor: an end to the Yom Kippur headache. Headache. 2006;46(10):1487-91. (Pubitemid 44722186)
44. • Camboim Rockett F, Castro K, de Oliveira Rossoni V, da Silveira Perla A, Fagundes Chaves ML, Schweigert Perry ID. Perceived migraine triggers: do dietary factors play a role? Nutr Hosp. 2012;27(2):483-9. Using survey data, the authors use both specific and non-specific behaviors and items, including food or food groups, to assess self reported triggers. Acknowledging the biases and difficulties with self-report, this study confirms previous large epidemiologic sampling with the addition of the importance of hunger as the second most cited trigger.
45. Drescher MJ, Wimpfheimer Z, Abu Khalef S, et al. Prophylactic etoricoxib is effective in preventing "first of Ramadan" headache: a placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache. Headache. 2012;52:573-81.
46. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505. (Pubitemid 36026261)
47. Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health. 2002;31(2):154-61. (Pubitemid 34786781)
48. • Ramsden CE, Faurot KR, Zamora D, Suchindran CM, Macintosh BA, Gaylord S et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial. Pain. 2013. doi: 10.1016/j.pain.2013.07.028. As a part of a series of papers resulting from a NIH/NICAM grant, the authors describe the trials and outcomes. With citations 77 & 78, the reader will be brought up to date on this interesting area of research, translating biological and clinical data into a series of real world recommendations.
49. Eccles JC. Developing concepts of the synapses. J Neurosci. 1990;10(12):3769-81.
50. Spigt M, Weerkamp N, Troost J, van Schayck CP, Knottnerus JA. A randomized trial on the effects of regular water intake in patients with recurrent headaches. Fam Pract. 2012;29:370-5.
51. Amandusson A, Blomqvist A. Estrogenic influences in pain processing. Front Neuroendocrinol. 2013. doi: 10.1016/j.yfrne.2013.06.001.
52. Smith AW, Bosch MA, Wagner EJ, Rønnekleiv OK, Kelly MJ. The membrane estrogen receptor ligand STX rapidly enhances GABAergic signaling in NPY/AgRP neurons: role in mediating the anorexigenic effects of 17β-estradiol. Am J Physiol Endocrinol Metab. 2013. doi: 10.1152/ajpendo.00281.2013.
53. Messina G, Viggiano A, De Luca V, Messina A, Chieffi S, Monda M. Hormonal changes in menopause and orexin-a action. Obstet Gynecol Int. 2013;2013:209812.
54. Quirk SE, Williams LJ, O'Neil A, Pasco JA, Jacka FN, Housden S, et al. The association between diet quality, dietary patterns and depression in adults: a systematic review. BMC Psychiatry. 2013;13(1):175.
55. Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010. doi: 10.1136/bmj.c5222.
56. Young WB. Preventive treatment of migraine: effect on weight. Curr Pain Headache Rep. 2008;12(3):201-6.
57. Taylor FR. Weight change associated with the use of migraine-preventive medications. Clin Ther. 2008;30(6):1069-80. (Pubitemid 351978119)
58. Berge LI, Riise T, Fasmer OB, et al. Does diabetes have a protective effect on migraine? Epidemiology. 2013;53:514-25.
59. Ford S, Finkel AG, Isaacs KL. Migraine in patients with inflammatory bowel disorders. J Clin Gastroenterol. 2009;43(5):499.
60. Maizels M et al. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44:885-90. (Pubitemid 39362312)
61. O'Brien, HL and Hershey AD. Vitamins and paediatric migraine: riboflavin as a preventative medication. Cephalalgia. 2010;30: 1417-18.
62. Schoenen J et al. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1999;50:466-70.
63. Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, Talebi M, Nikniaz Z, Safaiyan A. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res. 2012;150:42-8.
64. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009;25:446-52.
65. Cady RK, Farmer K, Dexter JK, Hall J. The bowel and migraine: update on celiac disease and irritable bowel syndrome. Curr Pain Headache Rep. 2012;16:278-86.
66. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil. 2013;19(3):301-11.
67. • Aydinlar EI, Dikmen PY, Tiftikci A, Saruc M, Aksu M, Gunsoy HG, et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache. 2013;53(3):514-25. This paper details the course of patients with IBS, identified IgG elevations to certain foods and a dietary intervention to reduce provocation. Through validated instruments and clinical assessment, patients were found to have concurrent improvement in IBS, migraine and quality of life.
68. Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2013. doi: 10.1136/gutjnl-2012-304066.
69. Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, et al. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012;36(11-12):1009- 31.
70. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011;12(10):570-84.
71. Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001;41(7):629-37. (Pubitemid 32777745)
72. Blasbalg TL, Hibbeln JR, Ramsden CE, et al. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011;93:950-62.
73. Pradlier A, Bakouche P, Baudesson G, et al. Failure of omega-3polyunsaturated fatty acids in prevention of migraine: a double blind study versus placebo. Cephalalgia. 2001;21:818-22. (Pubitemid 34621527)
74. Ramsden CE, Mann JD, Faurot KR, et al. Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial. Trials. 2011;12:97.
75. Ramsden CE, Ringel A, Feldstein AE, et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot Essent Fatty Acids. 2012;87:135-41.
76. Perez-Leighton CE, Billington CJ, Kotz CM. Orexin modulation of adipose tissue. Biochim Biophys Acta. 2013. doi: 10.1016/j.bbadis.2013.06.007.
77. Bigal ME, Lipton RB. Putative mechanisms of the relationship between obesity and migraine progression. Curr Pain Headache Rep. 2008;12(3):207-12.
78. • Peterlin BL, Rapoport AM, Kurth T. Migraine and obesity: epidemiology, mechanisms, and implications. Headache. 2010;50(4):631-48. Though a somewhat older paper, this still remains the clearest dissertation on the subject and questions necessary to answer going forward.
79. Holland P, Goadsby PJ. The hypothalamic orexinergic system: pain and primary headaches. Headache. 2007;47(6):951-62. (Pubitemid 46944378)
80. Lutter M, Krishnan V, Russo SJ, Jung S, McClung CA, Nestler EJ. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci. 2008;28(12):3071-5. (Pubitemid 351442272)
81. Sarchielli P, Rainero I, Coppola F, Rossi C, Mancini M, Pinessi L, et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia. 2008;28(7):714-22. (Pubitemid 351799744)
82. Hoever P, Hay J, Rad M, Cavallaro M, van Gerven JM, Dingemanse J. Tolerability, pharmacokinetics, and pharmacodynamics of single-dose almorexant, an orexin receptor antagonist, in healthy elderly subjects. J Clin Psychopharmacol. 2013;33(3):363-70.
83. Loder E. What is the evolutionary advantage of migraine? Cephalalgia. 2002;22(8):624-32. (Pubitemid 36609332)